ABCG2 and type 2 diabetes mellitus: These data suggest that the presence of the functionally impaired ABCG2-Q141K variant, even in properly managed patients, corresponds to an impaired treatment effect of T2DM patients, regarding both their short-term and long-term blood glucose levels.